ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2014 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/28/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. NVDA
9. FDXF
10. RKLB

Go back to ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2014 Financial Results

ImmunoCellular Therapeutics (IMUC) Tops Q4 EPS by 2c

March 9, 2015 4:15 PM EDT

ImmunoCellular Therapeutics (NYSE: IMUC) reported Q4 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05).

For earnings history and earnings-related data on ImmunoCellular Therapeutics (IMUC) click here.

... More